Healthcare -
Biotechnology - NASDAQ - US
$ 6.84
-8.91 %
$ 499 M
Market Cap
-10.53
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Arvinas, Inc.
| Revenue | 263 M |
| Cost Of Revenue | 6.6 M |
| Gross Profit | 257 M |
| Operating Expenses | 514 M |
| Operating Income | -250 M |
| Other Expenses | -51.3 M |
| Net Income | -199 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 263.4 | 78.5 | 131.4 | 46.7 | 21.8 | 43.0 | 14.3 | 7.6 | 6.7 |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 6.6 | 0 | 8.2 | 6.0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 256.8 | 78.5 | 123.2 | 40.7 | 21.8 | 43.0 | 14.3 | 7.6 | 6.7 |
| OPERATING INCOME | |||||||||
| Operating Expenses | 513.6 | 480.0 | 394.6 | 242.0 | 146.7 | 94.5 | 58.1 | 32.3 | 23.1 |
| Selling, General and Administrative Expenses | 165.4 | 100.3 | 79.6 | 61.6 | 38.3 | 27.3 | 12.9 | 3.5 | 3.2 |
| Research and Development Expenses | 348.2 | 379.7 | 315.0 | 180.4 | 108.4 | 67.2 | 45.2 | 28.8 | 19.9 |
| Operating Income | (250.2) | (401.5) | (263.2) | (195.3) | (124.9) | (51.5) | (43.8) | (24.8) | (16.5) |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | 0 | 0 | 12.0 | 100 K | 65 K | 85.6 K | 57.4 K | 50.4 K | 67.4 K |
| Total Other Income | 51.9 | 37.6 | 12.2 | (2.6) | 1.5 | (18.8) | 2.3 | 0.7 | 2.0 |
| Pre-Tax Income | (198.3) | (363.9) | (251.0) | (191.0) | (119.3) | (70.3) | (41.5) | (24.0) | (14.4) |
| NET INCOME | |||||||||
| Tax Provision | 0.6 | 0.9 | 20.9 | (7.8) | (7.5) | (8.2) | 2.4 | 0.6 | 87.4 K |
| Net Income | (198.9) | (367.3) | (271.9) | (183.2) | (111.8) | (62.1) | (41.5) | (24.0) | (14.4) |
| EPS | 2.77 | 6.62 | 5.11 | 3.66 | 2.83 | 1.89 | 4.4 | 1.16 | 0.8 |